SCHEMBL7760771

SCHEMBL7760771

NCOC(=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6242798 0.85 CYP1A2 (0.44)
SCHEMBL29037422 0.84
SCHEMBL27797181 0.81 CYP1A2 (0.38)
SCHEMBL1401913 0.80 CYP1A2 (0.52)
SCHEMBL8007867 0.79 MGAM (0.50)
SCHEMBL27713953 0.78 DGKA (0.50)
Ammonia Solution, Strong SCHEMBL27715433 0.77 MAPT (0.42)
SCHEMBL183889 0.77
SCHEMBL27846391 0.77
SCHEMBL6242803 0.76 LMNA (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1166689-C Purification method of hemoglobin ض� 2004-09-15 CN claimed
CN-1308636-A Purification method of hemoglobin BIOPURE CORP (US) 2001-08-15 CN claimed
CN-109475516-A Crystal 埃罗米克斯公司 2019-03-15 CN disclosed
CN-107007546-A For the oxymetazoline drug cream composition for the symptom for treating rosacea 阿勒根公司 2017-08-04 CN disclosed
CN-103458897-A Oxymetazoline pharmaceutical cream composition for treating symptoms of rosacea ALLERGAN INC 2013-12-18 CN disclosed
CN-1166689-C Purification method of hemoglobin ض� 2004-09-15 CN disclosed
CN-1308636-A Purification method of hemoglobin BIOPURE CORP (US) 2001-08-15 CN disclosed
EP-1097171-A1 METHOD FOR PURIFYING HEMOGLOBIN BIOPURE CORPORATION (US) 2001-05-09 EP disclosed
WO-2000002921-A1 METHOD FOR PURIFYING HEMOGLOBIN BIOPURE CORPORATION (US) 2000-01-20 WO disclosed